Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 1 / 6 Announcement Summary Entity name PERCHERON THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement 1/9/2026 The Proposed issue is: Total number of +securities proposed to...
Proposed issue of securities - PER
Filed with ASX ·
6ix hasn’t read this filing yet.
Percheron Therapeutics Limited on 6ix
In the deck
Earlier from Percheron Therapeutics
- Initial Director's Interest Notice
- Transitional appointment of Executive Director
- Change of Director's Interest Notice
- Notification of cessation of securities - PER
- Percheron receives $0.70m R&D Tax Incentive Rebate
Later from Percheron Therapeutics
- Percheron raises $2.3m to fully fund clinical trial in AML
- Percheron Therapeutics Limited Corporate Presentation
- 2026 Notice of Annual General Meeting
- Application for quotation of securities - PER
- Notice under S708A
Follow Percheron Therapeutics into a list and get an email when it puts out news.
Follow Percheron Therapeutics